This forum is for the discussion of anything to do with Prostate Cancer. There are only four rules:
No fundraisers, no commercials (although it is OK to recommend choices of treatment or medical people based on your personal research; invitations to participate in third-party surveys are also acceptable, provided there is no compensation to YANA);
No harvesting e-mail addresses for Spam;
No insults or flaming - be polite and respectful at all times and understand that there may be a variety of points of view, all of which may have some validity;
Opinions are OK, but please provide as much factual evidence as possible for any assertions that you are making
Failure to abide by these simple rules will result in the immediate and permanent suspension of your posting privileges.
Since this is an International Forum, please specify your location in your post.
Some men have pinned their hopes for a good outcome on treatment which includes, in part, a finasteride, i.e., a 5-AR reduction product. Perhaps the following excerpt from Clinicalendocrinologynews.com may help men to consider their options.
Men who took finasteride to prevent prostate cancer as part of a randomized clinical trial that ended in 2003 had the same long-term mortality as did those who took placebo, according to a report published online Aug. 14 in the New England Journal of Medicine.
The 15-year survival was approximately 78% in both groups, said Dr. Ian M. Thompson Jr. of the Cancer Research and Therapy Center, University of Texas Health Science Center at San Antonio, and his associates.
If your Testosterone returns to mid normal levels it is unlikely you will have any of the side effects you mention. Keep in mind that studies have shown that 5a reductase inhibitors double your vacation time when you are on intermittent ADT3.